| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 573 | 635 | 644 | 648 | 684 | 727 | 743 | 785 |
| Expenses | 405 | 494 | 467 | 454 | 476 | 498 | 502 | 511 |
| EBITDA | 168 | 140 | 177 | 194 | 208 | 229 | 241 | 274 |
| Operating Profit % | 29 % | 20 % | 27 % | 29 % | 28 % | 31 % | 32 % | 35 % |
| Depreciation | 19 | 27 | 28 | 28 | 28 | 28 | 28 | 30 |
| Interest | 26 | 32 | 26 | 22 | 21 | 21 | 18 | 16 |
| Profit Before Tax | 124 | 81 | 122 | 144 | 160 | 180 | 195 | 228 |
| Tax | 22 | 17 | 27 | 31 | 31 | 32 | 43 | 47 |
| Net Profit | 102 | 64 | 96 | 113 | 130 | 148 | 152 | 181 |
| EPS in ₹ | 6.14 | 3.84 | 5.75 | 6.80 | 7.80 | 8.88 | 9.07 | 10.81 |
Inventurus Knowledge Solutions
Inventurus Knowledge Solutions
1,696.00
+15.40
(0.92%)
Market Cap
₹29,098.81 Cr
PE Ratio
44.73
Volume
5,23,749.00
Day High - Low
₹1,727.10 - ₹1,670.00
52W High-Low
₹2,189.00 - ₹1,236.80
Key Fundamentals
Market Cap
29,098.81 Cr
EPS
29.20
PB Ratio
12.17
Book Value
130.54
EBITDA
808.70
Dividend Yield
0.00 %
Industry
Information Technology Sector
IT Enabled Services ROE Growth %
-
Debt to Equity
0.74
Analyst Rating and Forecast
- By Refinitiv from4 analysts
Actual
Company News
View All News
IKS Health inaugurated a state-of-the-art 1,000-seat facility in Coimbatore designed to accommodate rapid expansion of operations for the US healthcare market and serve as a talent hub for graduates and experienced professionals. The company reported 22% year-over-year revenue growth and 60% rise in Profit After Tax for the second quarter of Fiscal Year 2026, with the expansion aimed at enhancing execution capacity for long-term objectives in the US market.
Inventurus Knowledge Solutions Limited (IKS Health) reported revenue of INR 781 crores for Q2 FY26, representing 22% year-on-year growth and 5.5% quarter-on-quarter growth. EBITDA reached INR 272 crores with margins of 35%, showing 43% year-on-year growth. PAT stood at INR 181 crores, reflecting 60% year-on-year growth. The company achieved these results ahead of its margin expansion timeline, driven by AI implementation across its platform and transformation of the AQuity delivery model. IKS Health secured significant new clients including AdventHealth, Revere Health, Jackson Clinic, and a leading cardiology group. The company continues to focus on its AI-native platform transformation and cross-selling initiatives within its existing customer base. Top 10 customers now comprise 45% of revenue with an average tenure of six years. Operating cash flow was INR 291 crores with free cash flow of INR 225 crores.
Inventurus Knowledge Solutions Limited announced a change in Senior Management Personnel effective from close of business hours on October 30, 2025. Mr. Sameer Arora will assume a new role within the company due to changes in internal role, designation and responsibilities. Following this change, he will no longer be classified as Senior Management Personnel under the provisions of the Companies Act, 2013 and SEBI LODR Regulations. The company trades on BSE with scrip code 544309 and on NSE with symbol IKS.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
4,385.20 | #1 46,473.88 | 35.97 | #1 10,880.10 | 10.41 | #1 1,264 | 2.87 | 60.80 | |
1,696.00 | #2 29,098.81 | #6 44.73 | #6 2,703.00 | #2 45.49 | #5 486 | #4 59.91 | 62.52 | |
677.55 | 27,489.01 | 39.77 | 5,292.60 | 1.14 | 677 | 5.15 | 46.72 | |
1,673.20 | 23,531.92 | 57.66 | 2,360.10 | 24.22 | 382 | 20.11 | 30.20 | |
49.87 | 23,345.78 | 29.04 | 5,626.20 | 17.67 | 539 | #1 113.81 | 51.16 | |
1,113.30 | 12,367.33 | #1 20.76 | 7,457.00 | 3.38 | 648 | -23.42 | 40.97 | |
557.20 | 9,471.70 | 41.26 | 5,971.90 | -5.22 | 205 | 9.00 | 56.27 | |
1,424.70 | 6,054.64 | 71.07 | 1,051.60 | 8.33 | 75 | 87.80 | 42.47 | |
383.30 | 5,145.96 | 46.25 | 1,330.50 | #1 69.08 | 88 | 72.41 | 54.35 | |
617.70 | 5,115.28 | 52.39 | 527.80 | 38.89 | 87 | 18.39 | 42.69 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
45.49 %
Net Income Growth
31.20 %
Cash Flow Change
51.54 %
ROE
-15.13 %
ROCE
22.60 %
EBITDA Margin (Avg.)
-0.80 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 586 | 788 | 988 | 3,028 | 3,052 |
| Fixed Assets | 87 | 76 | 59 | 1,833 | 1,790 |
| Current Assets | 345 | 461 | 698 | 898 | 784 |
| Capital Work in Progress | 0 | 0 | 0 | 3 | 13 |
| Investments | 14 | 16 | 32 | 195 | 114 |
| Other Assets | 485 | 696 | 898 | 997 | 1,135 |
| Total Liabilities | 586 | 788 | 988 | 3,028 | 3,052 |
| Current Liabilities | 59 | 83 | 115 | 790 | 521 |
| Non Current Liabilities | 70 | 58 | 45 | 1,080 | 741 |
| Total Equity | 457 | 647 | 829 | 1,158 | 1,790 |
| Reserve & Surplus | 448 | 630 | 812 | 1,140 | 1,773 |
| Share Capital | 8 | 17 | 17 | 17 | 17 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 43 | -28 | 92 | -22 | -147 | 170 |
| Investing Activities | -79 | -167 | -82 | -158 | -1,137 | 241 |
| Operating Activities | 163 | 175 | 233 | 288 | 210 | 318 |
| Financing Activities | -41 | -37 | -59 | -152 | 780 | -390 |
Share Holding
| % Holding | Aug 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 69.73 % | 63.72 % | 63.72 % | 63.72 % | 63.72 % |
| FIIs | 0.00 % | 5.48 % | 5.39 % | 6.50 % | 7.02 % |
| DIIs | 0.00 % | 4.45 % | 4.03 % | 4.33 % | 4.89 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 10.25 % | 10.93 % | 10.81 % | 10.83 % |
| Others | 30.27 % | 16.10 % | 15.93 % | 14.64 % | 13.53 % |
| No of Share Holders | 110 | 109 | 57,714 | 59,218 | 57,577 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 05 Feb 2025 |  Quarterly Result Announcement | NA | 05 Feb 2025 | 1,915.20 | 1,724.05 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 1,420.20 | 1,647.20 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 1,604.60 | 1,578.70 |
| 23 Sept 2025 |  Annual General Meeting | NA | 23 Sept 2025 | 1,512.80 | 1,498.00 |
| 30 Oct 2025 | Quarterly Result Announcement | NA | 30 Oct 2025 | 1,504.90 | 1,569.40 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Nov 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 30, 2025
Oct 30, 2025Unaudited Standalone And Consolidated Financial Results Of The
Company For The Quarter And Half Year Ended September 30 2025.Oct 30, 2025
Oct 30, 2025Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI LODR Regulations - Outcome Of The Board Meeting Held On October 30 2025 - Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended SepteOct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Oct 28, 2025Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) - Issuance Of Corporate Guarantee.Oct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 17, 2025
Oct 17, 2025Announcement under Regulation 30 (LODR)-AcquisitionOct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 16, 2025
Oct 16, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)Oct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Intimation Of Change In Email Address Of The MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company.Oct 03, 2025
Oct 03, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 03, 2025
Oct 03, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 01, 2025
Sep 01, 2025Letter Sent To MembersAug 30, 2025
Aug 30, 2025Notice Convening The 19Th Annual General Meeting (AGM)Aug 30, 2025
Aug 30, 2025Reg. 34 (1) Annual Report.Aug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 06, 2025
Aug 06, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order Received By Aquity Solutions India Private Limited A Wholly-Owned Subsidiary Of The Company From The Interim Settlement Board - III Ministry Aug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 01, 2025
Aug 01, 2025Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of The Board Meeting Held On July 31 2025.Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of The Board Meeting Held On July 31 2025.Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 24, 2025
Jul 24, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jul 24, 2025
Jul 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Mutual Fund Holdings
PGIM India Flexi Cap Fund Direct-Growth 
ICICI Prudential Technology Direct Plan-Growth 
HDFC Multi Cap Fund Direct - Growth 
Union Flexi Cap Fund Direct-Growth 
Tata Balanced Advantage Fund Direct - Growth 
Mirae Asset Flexi Cap Fund Direct - Growth 
WhiteOak Capital Digital Bharat Fund Direct-Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty 500 Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 60.83
ATR(14)
Volatile 47.78
STOCH(9,6)
Neutral 42.17
STOCH RSI(14)
Neutral 55.54
MACD(12,26)
Bullish 0.64
ADX(14)
Weak Trend 19.04
UO(9)
Bearish 50.92
ROC(12)
Uptrend And Accelerating 0.33
WillR(14)
Overbought -11.98
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
